Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

MYLAN-ALMOTRIPTAN

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MYLAN-ALMOTRIPTAN in Canada?

A shortage of MYLAN-ALMOTRIPTAN 12.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 14, 2026), but it has not started yet.

Why is MYLAN-ALMOTRIPTAN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MYLAN-ALMOTRIPTAN be available again?

The manufacturer's estimated resolution date is February 9, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Expected resolution~4 months remaining (estimate)
Affected strength12.5MG
Last updated2026-09-14

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PMS-ALMOTRIPTAN

PHARMASCIENCE INC

12.5MG · DIN 02441411

Same strengthSame dosage formSame routeNo current shortage

ALMOTRIPTAN

PRO DOC LIMITEE

12.5MG · DIN 02424029

Same strengthSame dosage formSame routeNo current shortage

SANDOZ ALMOTRIPTAN

SANDOZ CANADA INCORPORATED

12.5MG · DIN 02405334

Same strengthSame dosage formSame routeNo current shortage

JAMP ALMOTRIPTAN

JAMP PHARMA CORPORATION

12.5MG · DIN 02556030

Same strengthSame dosage formSame routeNo current shortage

Other Products

MYLAN-ALMOTRIPTAN

MYLAN PHARMACEUTICALS ULC

6.25MG · DIN 02398435

Different strengthSame dosage formSame routeNo current shortage

AG-ALMOTRIPTAN

ANGITA PHARMA INC.

6.25MG · DIN 02570289

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2027-02-09

~4 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02398443

Strength

12.5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ALMOTRIPTAN

Tier

Unrated

Last Updated

2026-09-14

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

MYLAN-ALMOTRIPTAN has 3 shortage/discontinuation reports on file — this is one of them.